Stine Bordier Hoj
Overview
Explore the profile of Stine Bordier Hoj including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
48
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fontaine G, Presseau J, Bruneau J, Etherington C, Thomas I, Hung J, et al.
Int J Equity Health
. 2024 Jun;
23(1):124.
PMID: 38886803
Background: Hepatitis C virus (HCV) infection is a significant global health burden, particularly among people who inject drugs. Rapid point-of-care HCV testing has emerged as a promising approach to improve...
2.
Makarenko I, Minoyan N, Hoj S, Udhesister S, Martel-Laferriere V, Jutras-Aswad D, et al.
Drug Alcohol Rev
. 2024 May;
43(7):2077-2088.
PMID: 38741361
Introduction: Limited data exists on psychological impacts of the COVID-19 pandemic among people who use drugs (PWUD). This study aimed to determine the prevalence and correlates of severe psychological distress...
3.
Hoj S, Minoyan N, Zang G, Larney S, Bruneau J
Drug Alcohol Depend
. 2023 Sep;
251:110956.
PMID: 37716286
Background: Amphetamine injection is expanding in North America and has been associated with male homosexuality among people who inject drugs (PWID). Applying subcultural evolution theory, we examined overall and gender-stratified...
4.
Hoj S, de Montigny C, Chougar S, Leandre R, Beauchemin-Nadeau M, Boyer-Legault G, et al.
JMIR Public Health Surveill
. 2023 Jul;
9:e39236.
PMID: 37494097
The COVID-19 pandemic triggered unprecedented expansion of telemedicine, including in the delivery of opioid agonist treatment (OAT) for people with opioid use disorder (OUD). However, many people with OUD lack...
5.
Fontaine G, Presseau J, Bruneau J, Patey A, van Allen Z, Mortazhejri S, et al.
Int J Drug Policy
. 2023 Jul;
121:104124.
PMID: 37451942
Background: Access to hepatitis C care within harm reduction community organizations for people who inject drugs is crucial for achieving hepatitis C elimination. However, there is a lack of data...
6.
Jiang N, Bruneau J, Makarenko I, Minoyan N, Zang G, Hoj S, et al.
Int J Drug Policy
. 2023 Feb;
113:103954.
PMID: 36758334
Background: Barriers to HCV treatment initiation persisted after the introduction of direct-acting antivirals (DAAs) in Canada among people who inject drugs (PWID); whether DAA universal coverage lifted these barriers remain...
7.
Hoj S, Minoyan N, Artenie A, Grebely J, Bruneau J
Can Liver J
. 2022 Aug;
1(2):4-13.
PMID: 35990720
Background: The worldwide economic, health, and social consequences of drug use disorders are devastating. Injection drug use is now a major factor contributing to hepatitis C virus (HCV) transmission globally,...
8.
Minoyan N, Hoj S, Zolopa C, Vlad D, Bruneau J, Larney S
Harm Reduct J
. 2022 Apr;
19(1):38.
PMID: 35436936
Background: People who use drugs (PWUD) are at high risk of experiencing indirect harms of measures implemented to curb the spread of COVID-19, given high reliance on services and social...
9.
Fortier E, Hoj S, Sylvestre M, Artenie A, Minoyan N, Jutras-Aswad D, et al.
Int J Drug Policy
. 2021 Sep;
96:103439.
PMID: 34518099
Background: Frequent injecting increases hepatitis C (HCV) acquisition risk among people who inject drugs (PWID). However, few studies have examined how temporal fluctuations in injecting frequency may effect HCV infection...
10.
Hoj S, Bruneau J, Hickman M
Eur J Public Health
. 2021 Sep;
31(4):670-671.
PMID: 34492109
No abstract available.